Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 306 recruiting now early-phase tilt #3 of 28,963 conditions

Obesity: early-phase trial registry

306 of 1,057 indexed Obesity trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3 of 28,963 conditions by registered trial count.

1,057 US clinical trials · 306 currently recruiting · #3 of 28,963 conditions by registered trial count

Obesity: 1,057 US clinical trials tracked, 306 recruiting.

Obesity is the subject of 1,057 registered US clinical trials on ClinicalTrials.gov, 306 of them currently open to new participants. 107 are in Phase 3-4 (later-stage) and 196 in Phase 1-2 (earlier-stage). The most active sponsor is Eli Lilly and Company, running 48 of these trials.

Open enrollment, early-phase tilt

Obesity has 1,057 registered US clinical trials, 306 of them open to new participants right now, about 29% of the total.

306
recruiting participants now
29%
of trials open to enrollment
107
in Phase 3-4 (later-stage)
48
top sponsor: Eli Lilly and Company

Corpus placement: #3 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Obesity on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity is recruiting below its size-band peers.

    306 of 1,057 indexed trials (28.9%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Obesity trials is spread across many organizations.

    Eli Lilly and Company accounts for 48 of 1,057 trials (4.5%). 314 distinct sponsors appear on at least one study for this condition label.

  3. Typical Obesity enrolment sits around 90 participants.

    Median target enrolment is 90 among the 1,054 trials that report a genuine target (sentinel values excluded). 555 of those (52.7%) plan for fewer than 100 participants.

  4. Obesity research is mostly interventional.

    894 interventional and 163 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 195Phase 2101Phase 369Phase 438

Open and recent trials

1,057 total, page 20 of 22

COMPLETED NA 26 participants

Effect of Increased Free Fatty Acids on Leptin Function

Beth Israel Deaconess Medical Center

NCT01520454

COMPLETED NA 25 participants

Pilot Study: Identification of a Multi-omic Predictive Signature for Preterm Birth in Obese African American Women

Baylor University

NCT03181555

COMPLETED Phase 2 25 participants

Qsymia as an Adjunct to Surgical Therapy in the Superobese

Wake Forest University Health Sciences

NCT02301416

COMPLETED NA 25 participants

Fruit And Vegetable Or Recreation Prescriptions for UW-Madison Students

University of Wisconsin, Madison

NCT02870322

COMPLETED Phase 1 24 participants

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Pfizer

NCT00645021

COMPLETED Phase 2 24 participants

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

Incyte Corporation

NCT00478322

COMPLETED Phase 1 24 participants

Fecal Microbiota Transplant for Improvement of Metabolism

Massachusetts General Hospital

NCT02530385

COMPLETED Phase 1 24 participants

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

University of Colorado, Denver

NCT03620773

COMPLETED NA 24 participants

Carnitine and Liver Mitochondria Fatty Acid Processing

Pennington Biomedical Research Center

NCT03193125

COMPLETED NA 24 participants

Effects of Guided Exercise on Functional Performance and Independence in Adults With Intellectual Disability

University of Delaware

NCT04616638

COMPLETED NA 24 participants

Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study

Medical University of South Carolina

NCT05742646

COMPLETED NA 24 participants

Multivitamin Adherence Following Bariatric Surgery

Wake Forest University Health Sciences

NCT02124889

COMPLETED Phase 1 24 participants

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

Kallyope

NCT05890950

COMPLETED NA 24 participants

Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia

Yale University

NCT00793780

COMPLETED NA 24 participants

Leisure Time Activity and Nutrition Program

The University of Tennessee, Knoxville

NCT00656045

COMPLETED Phase 2 24 participants

Leptin in the Maintenance of Reduced Body Weight

Beth Israel Deaconess Medical Center

NCT01155180

COMPLETED NA 24 participants

mTORC1 and Autophagy in Human Brown Adipocytes

University of New Mexi

NCT04206124

COMPLETED Phase 1 23 participants

The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity

Sara Espinoza

NCT03119610

COMPLETED NA 23 participants

Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

Stanford University

NCT03935854

COMPLETED NA 23 participants

Resistance Training and Appetite Regulation

University of Colorado, Denver

NCT03985787

COMPLETED Phase 4 23 participants

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Michael Stitely

NCT01755026

COMPLETED NA 23 participants

Assessment of Endogenous Oxalate Synthesis

University of Alabama at Birmingham

NCT05229952

COMPLETED NA 23 participants

Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy

University of Illinois at Chicago

NCT04810546

COMPLETED NA 23 participants

Pathways Linking Reduced Sleep Duration and Quality to Obesity Risk

University of Chicago

NCT00915707

COMPLETED Phase 1 22 participants

Nutrition and Soccer for Pediatric Overweight and Obesity

Leach Chiropractic Clinic

NCT00365651

COMPLETED NA 22 participants

Relation of Obesity With Frequency of Meals (MST 0557)

Rockefeller University

NCT00229255

COMPLETED Phase 1 22 participants

Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile

Phillip Brian Smith

NCT01744730

COMPLETED NA 22 participants

The TREND Study: Tapered Reduction in Energy Intake as a Novel Approach to Dieting

Wake Forest University Health Sciences

NCT02837211

COMPLETED 21 participants

Metabolic and Cardiovascular Impact of CD36 Deficiency in African Americans

Vanderbilt University Medical Center

NCT02126735

COMPLETED NA 21 participants

Vasoprotective Activities of Low-Fat Milk in Individuals With Metabolic Syndrome

University of Connecticut

NCT01411293

COMPLETED NA 21 participants

Addressing Emotional and Cognitive Factors in Behavioral Weight Loss Treatment

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00533052

COMPLETED NA 21 participants

Appetite and Exercise in Breast Cancer Survivors

University of Colorado, Denver

NCT04300478

COMPLETED NA 20 participants

The Effect of Exercise on Hepatic Glucose Metabolism

Vanderbilt University

NCT01783275

COMPLETED NA 20 participants

The Effects Grapes on Health Indices

University of California, Davis

NCT01674231

COMPLETED NA 20 participants

Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility

VA Office of Research and Development

NCT02806336

COMPLETED NA 20 participants

Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis

Purdue University

NCT05349903

COMPLETED 20 participants

Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition

University of Wisconsin, Madison

NCT02843256

COMPLETED NA 20 participants

Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry

University of California, San Diego

NCT03138382

COMPLETED NA 20 participants

The DEB Pilot Study

Pennington Biomedical Research Center

NCT03190993

COMPLETED Phase 2 20 participants

PRebiotic to IMprovE Calcium Absorption

San Francisco Veterans Affairs Medical Center

NCT03272542

COMPLETED Phase 4 20 participants

Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

Mayo Clinic

NCT02160990

COMPLETED Phase 1 20 participants

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Pfizer

NCT05677867

COMPLETED 20 participants

Mechanisms of Diabetes Control After Weight Loss Surgery

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NCT00571220

COMPLETED NA 20 participants

High Fat Diet II on Weight Loss

Christiana Care Health Services

NCT00525850

COMPLETED NA 19 participants

Impact of a Childhood Obesity Intervention for African American Families

University of California, Berkeley

NCT02044731

COMPLETED 19 participants

Gut Microbiota Post Roux-en-Y Gastric Bypass Surgery

North Dakota State University

NCT02654496

COMPLETED NA 19 participants

A Study of a Values-Based Intervention to Promote Weight Loss

Drexel University

NCT03991676

COMPLETED Phase 1 19 participants

Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents

Mayo Clinic

NCT01746264

COMPLETED 19 participants

Sex and Obesity: Effects on Heart Failure Study

Washington University School of Medicine

NCT00776035

COMPLETED NA 19 participants

Health At Every Size and Acceptance and Commitment Therapy vs. Behavioral Weight Loss for Obesity and Depression in Women

Dartmouth-Hitchcock Medical Center

NCT02501239

← Previous Page 20 of 22 Next →

Phase Distribution

PhaseTrial count
Phase 1 95
Phase 2 101
Phase 3 69
Phase 4 38

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Obesity right now

306 recruiting of 1,057 indexed (29% open).

Phase mix: 107 late (III/IV) vs 196 early (I/II) (early-phase heavy).

Top sponsor: Eli Lilly and Company (48 trials), 9 others listed. 50 shown below, recruiting first. #3 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Obesity?

PlainTrial tracks 1,057 US clinical trials for Obesity, of which 306 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Obesity?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.